These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34075200)

  • 1. STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation.
    Kim D; Park G; Huuhtanen J; Ghimire B; Rajala H; Moriggl R; Chan WC; Kankainen M; Myllymäki M; Mustjoki S
    Leukemia; 2021 Dec; 35(12):3430-3443. PubMed ID: 34075200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell large granular lymphocyte leukemia and chronic NK lymphocytosis.
    Barilà G; Calabretto G; Teramo A; Vicenzetto C; Gasparini VR; Semenzato G; Zambello R
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):207-216. PubMed ID: 31585621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes.
    Olson KC; Kulling Larkin PM; Signorelli R; Hamele CE; Olson TL; Conaway MR; Feith DJ; Loughran TP
    Cytokine; 2018 Nov; 111():551-562. PubMed ID: 30455079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Large Granular Lymphocytic Leukemia and JAK/STAT Signaling Pathway--Review].
    Qiu ZY; Fan Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):254-60. PubMed ID: 26913432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic landscape of T-large granular lymphocyte leukemia and chronic lymphoproliferative disorder of NK cells: a single institution experience.
    Fei F; Stehr H; Zehnder JL
    Leuk Lymphoma; 2023 Sep; 64(9):1536-1544. PubMed ID: 37330635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients.
    Barilà G; Teramo A; Calabretto G; Vicenzetto C; Gasparini VR; Pavan L; Leoncin M; Vedovato S; Frigo AC; Facco M; Semenzato G; Zambello R
    Leukemia; 2020 Apr; 34(4):1116-1124. PubMed ID: 31740810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia.
    Shi M; He R; Feldman AL; Viswanatha DS; Jevremovic D; Chen D; Morice WG
    Hum Pathol; 2018 Mar; 73():74-81. PubMed ID: 29288042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.
    Jerez A; Clemente MJ; Makishima H; Koskela H; Leblanc F; Peng Ng K; Olson T; Przychodzen B; Afable M; Gomez-Segui I; Guinta K; Durkin L; Hsi ED; McGraw K; Zhang D; Wlodarski MW; Porkka K; Sekeres MA; List A; Mustjoki S; Loughran TP; Maciejewski JP
    Blood; 2012 Oct; 120(15):3048-57. PubMed ID: 22859607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis.
    Gorodetskiy VR; Sidorova YV; Kupryshina NA; Vasilyev VI; Probatova NA; Ryzhikova NV; Sudarikov AB
    Rheumatol Int; 2021 Jan; 41(1):147-156. PubMed ID: 33280072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D decreases STAT phosphorylation and inflammatory cytokine output in T-LGL leukemia.
    Olson KC; Kulling PM; Olson TL; Tan SF; Rainbow RJ; Feith DJ; Loughran TP
    Cancer Biol Ther; 2017 May; 18(5):290-303. PubMed ID: 27715403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic
    Savola P; Brück O; Olson T; Kelkka T; Kauppi MJ; Kovanen PE; Kytölä S; Sokka-Isler T; Loughran TP; Leirisalo-Repo M; Mustjoki S
    Haematologica; 2018 Feb; 103(2):304-312. PubMed ID: 29217783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.
    Kulling PM; Olson KC; Hamele CE; Toro MF; Tan SF; Feith DJ; Loughran TP
    PLoS One; 2018; 13(2):e0193429. PubMed ID: 29474442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia.
    Vicenzetto C; Gasparini VR; Barila G; Teramo A; Calabretto G; Rampazzo E; Carraro S; Trimarco V; Trentin L; Facco M; Semenzato G; Zambello R
    Haematologica; 2024 Jan; 109(1):163-174. PubMed ID: 37439335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large granular lymphocyte leukemia serum and corresponding hematological parameters reveal unique cytokine and sphingolipid biomarkers and associations with STAT3 mutations.
    Olson KC; Moosic KB; Jones MK; Larkin PMK; Olson TL; Toro MF; Fox TE; Feith DJ; Loughran TP
    Cancer Med; 2020 Sep; 9(18):6533-6549. PubMed ID: 32710512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker.
    Johansson P; Laguna T; Ossowski J; Pancaldi V; Brauser M; Dührsen U; Keuneke L; Queiros A; Richter J; Martín-Subero JI; Siebert R; Schlegelberger B; Küppers R; Dürig J; Murga Penas EM; Carillo-de Santa Pau E; Bergmann AK
    Clin Epigenetics; 2022 Nov; 14(1):148. PubMed ID: 36376973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.
    Rajala HL; Olson T; Clemente MJ; Lagström S; Ellonen P; Lundan T; Hamm DE; Zaman SA; Lopez Marti JM; Andersson EI; Jerez A; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
    Haematologica; 2015 Jan; 100(1):91-9. PubMed ID: 25281507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic STAT3 mutations in large granular lymphocytic leukemia.
    Koskela HL; Eldfors S; Ellonen P; van Adrichem AJ; Kuusanmäki H; Andersson EI; Lagström S; Clemente MJ; Olson T; Jalkanen SE; Majumder MM; Almusa H; Edgren H; Lepistö M; Mattila P; Guinta K; Koistinen P; Kuittinen T; Penttinen K; Parsons A; Knowles J; Saarela J; Wennerberg K; Kallioniemi O; Porkka K; Loughran TP; Heckman CA; Maciejewski JP; Mustjoki S
    N Engl J Med; 2012 May; 366(20):1905-13. PubMed ID: 22591296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of T-cell large granular lymphoblastic leukemia with STAT3 gene mutation].
    Liu HL; Cao L; Zhao XL; Guo JJ; Qiao C; Zhu HY; Wang L; Xu W; Li JY; Fan L
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):495-501. PubMed ID: 34384156
    [No Abstract]   [Full Text] [Related]  

  • 19. STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia.
    Ishida F; Matsuda K; Sekiguchi N; Makishima H; Taira C; Momose K; Nishina S; Senoo N; Sakai H; Ito T; Kwong YL
    Cancer Sci; 2014 Mar; 105(3):342-6. PubMed ID: 24350896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia.
    Qiu ZY; Fan L; Wang L; Qiao C; Wu YJ; Zhou JF; Xu W; Li JY
    J Hematol Oncol; 2013 Oct; 6():82. PubMed ID: 24283217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.